Literature DB >> 17115089

[Low frequency fluctuating hearing loss without labyrinthine vertigo--a genuine disease? A follow up study after 4 and 10 years].

H Schaaf1, G Hesse.   

Abstract

BACKGROUND: Besides the typical attacks of dizziness, recurrent low-frequency sensory hearing loss--together with mostly low-frequency tinnitus--is also a characteristic sign of Menière's disease. It is therefore often assumed to be a prodromal sign of Menière's disease, even without dizziness.
METHODS: During our longitudinal study, which was started in 1995, we reported that there were 81 patients with recurrent low-frequency hearing loss with no initial vertigo in the first suspense year of 1999. After a further 6 years, we investigated 46 (57%) of these original 81 patients in the second suspense year, 2005, for new components of vertigo, with the questions of development of Menière's disease and further development of the patients' hearing ability and psychic situation in mind.
RESULTS: In all, 12 (26%) of the 81 former patients suffered from vertigo, but only 4 (9%) had developed the typical signs of full-blown Menière's disease with the typical labyrinthine vertigo. Of the 12 patients who suffered from vertigo, 6 (13% of the 81 with vertigo) were diagnosed with psychogenic vertigo, 1 (1%) suffered from benign and treatable paroxysmal positional vertigo and 1 (1%) had developed vertigo after acoustic neurinoma surgery.
CONCLUSIONS: We conclude from our observations that, although almost every patient with Menière's disease suffers from recurrent low-frequency hearing loss, only a few patients with recurrent hearing loss develop Menière's disease. However, many patients with low-frequency sensory hearing loss develop anxiety leading to psychogenic dizziness in fearful expectation of "imminent" Menière's disease. We found that 26% of the patients had persisting bilateral normacusis in the low-frequency ranges, while 34% had unilateral hearing loss that was sufficiently severe to affect their lives and 39%, bilateral hearing loss; however, none of the patients became completely deaf.

Entities:  

Mesh:

Year:  2007        PMID: 17115089     DOI: 10.1007/s00106-006-1495-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  21 in total

1.  [Proof of endolymphatic hydrops].

Authors:  S Hoth
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

2.  Long-term progression of Meniére's disease.

Authors:  J Stahle; U Friberg; A Svedberg
Journal:  Acta Otolaryngol Suppl       Date:  1991

3.  The endolymphatic sac as the immunocompetent organ of the inner ear.

Authors:  M Barbara; G Attanasio; V Petrozza; A Modesti; R Filipo
Journal:  Ann N Y Acad Sci       Date:  1997-12-29       Impact factor: 5.691

4.  Diagnosis of endolymphatic hydrops by low-frequency masking.

Authors:  D Mrowinski; G Scholz; S Krompass; K Nubel
Journal:  Audiol Neurootol       Date:  1996 Mar-Apr       Impact factor: 1.854

5.  [Increased summation potentials in patients with Menière's disease].

Authors:  G Hesse; A Mausolf
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1988-03

6.  Curing the BPPV with a liberatory maneuver.

Authors:  A Semont; G Freyss; E Vitte
Journal:  Adv Otorhinolaryngol       Date:  1988

7.  Possible roles of outer hair cell d.c. movements in the cochlea.

Authors:  H P Zenner
Journal:  Br J Audiol       Date:  1993-04

Review 8.  [Management of the patient with Meniere's disease. Clear diagnosis but vertigo-provoking perspective].

Authors:  H Schaaf; H Holtmann
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

9.  Acute low-tone sensorineural hearing loss without vertigo.

Authors:  T Yamasoba; S Kikuchi; M Sugasawa; M Yagi; T Harada
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-05

10.  Hearing results of intratympanic steroid treatment of endolymphatic hydrops.

Authors:  M A Arriaga; S Goldman
Journal:  Laryngoscope       Date:  1998-11       Impact factor: 3.325

View more
  2 in total

1.  [Utricular function. Correlation of three investigations carried out in routine practice].

Authors:  H Schaaf; G Kastellis; G Hesse
Journal:  HNO       Date:  2013-08       Impact factor: 1.284

2.  [Vertigo and fluctuating hearing-loss. Differential diagnosis: Ménière's disease, migraine, and psychogenic vertigo].

Authors:  H Schaaf; G Hesse
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.